| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Neil Blumberg | |
| Joanna M Heal | |||
| Gordon L Phillips | |||
| P2860 | cites work | The role of ABO matching in platelet transfusion | Q70578075 |
| An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions | Q79142074 | ||
| Release of potential immunomodulatory factors during platelet storage | Q79889339 | ||
| Platelet transfusion therapy | Q80709486 | ||
| Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury | Q83506859 | ||
| Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles | Q24655248 | ||
| A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440] | Q24801336 | ||
| Platelet washing to prevent recurrent febrile reactions to leucocyte-reduced transfusions | Q33337118 | ||
| Lowering the prophylactic platelet transfusion threshold: a prospective analysis | Q33337229 | ||
| Optimizing platelet transfusion therapy | Q33361167 | ||
| A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation | Q33369834 | ||
| Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients | Q33370872 | ||
| The clinical impact of platelet refractoriness: correlation with bleeding and survival | Q33380020 | ||
| The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. | Q33501152 | ||
| Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions | Q33501221 | ||
| Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia | Q33502337 | ||
| The platelet as an immune cell-CD40 ligand and transfusion immunomodulation | Q33937074 | ||
| New links between inflammation and thrombosis | Q36098709 | ||
| What would Karl Landsteiner do? The ABO blood group and stem cell transplantation | Q36207276 | ||
| Acute hemolytic transfusion reaction in a pediatric patient following transfusion of apheresis platelets | Q36304454 | ||
| Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer | Q37416199 | ||
| Platelet transfusion therapy: from 1973 to 2005. | Q40321979 | ||
| Increased risk of infection and mortality in women after cardiac surgery related to allogeneic blood transfusion. | Q40432667 | ||
| Evaluation of an automated culture system for detecting bacterial contamination of platelets: an analysis with 15 contaminating organisms | Q43584972 | ||
| Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes | Q44903709 | ||
| Platelets kill intraerythrocytic malarial parasites and mediate survival to infection | Q46131528 | ||
| Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A,B: implications for transfusion policy | Q47444455 | ||
| Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction. | Q52855197 | ||
| P304 | page(s) | 5 | |
| P577 | publication date | 2010-01-27 | |
| P1433 | published in | F1000 medicine reports | Q27722435 |
| P1476 | title | Platelet transfusions: trigger, dose, benefits, and risks | |
| P478 | volume | 2 |
| Q89667840 | Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 Studies |
| Q57689300 | Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders |
| Q37265484 | Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders. |
| Q50018924 | Efficacy of platelet transfusion for acute intracerebral hemorrhage among patients on antiplatelet therapy. |
| Q33403724 | Frequency of human platelet antigens in oncohematological patients with thrombocytopenia and the probability of incompatibility to platelet transfusions |
| Q38761691 | Is cold blood cardioplegia absolutely superior to cold crystalloid cardioplegia in aortic valve surgery? |
| Q91575261 | Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2) |
| Q90220402 | Management of Thrombocytopenia in Patients with Chronic Liver Disease |
| Q49899043 | Prophylactic platelet transfusions prior to surgery for people with a low platelet count |
| Q57156182 | Prophylactic platelet transfusions prior to surgery for people with a low platelet count |
| Q36515685 | Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults. |
| Q24187543 | Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia |
| Q26471928 | Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia |
| Q57689341 | Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia |
Search more.